Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 5, 2006, Pages 972-978

  Missmer, Stacey A ^a,b   Spiegelman, Donna ^b   Bertone Johnson, Elizabeth R ^c   Barbieri, Robert L ^a   Pollak, Michael N ^d   Hankinson, Susan E ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF MASSACHUSETTS   (United States)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; ESTRADIOL; ESTROGEN; ESTRONE SULFATE; PRASTERONE SULFATE; PROGESTERONE; PROLACTIN; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TESTOSTERONE;

ADULT; ARTICLE; BLOOD SAMPLING; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; LUTEAL PHASE; MENSTRUAL CYCLE; POSTMENOPAUSE; PRIORITY JOURNAL;

ADULT; ANDROGENS; BREAST NEOPLASMS; ESTROGENS; FEMALE; GONADAL STEROID HORMONES; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; PREMENOPAUSE; PROGESTERONE; PROLACTIN; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK; SEX HORMONE-BINDING GLOBULIN; STATISTICS, NONPARAMETRIC;

EID: 33644516398     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0848     Document Type: Article

References (42)

1. Key T, Appleby P, Barnes I, et al. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002;94:606-16.
2. Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 2002;11:1531-43.
3. Guthrie JR, Lehert P, Dennerstein L, Burger HG, Ebeling PR, Wark JD. The relative effect of endogenous estradiol and androgens on menopausal bone loss: a longitudinal study. Osteoporos Int 2004;15:881-6.
4. Rapuri PB, Gallagher JC, Haynatzki G. Endogenous levels of serum estradiol and sex hormone binding globulin determine bone mineral density, bone remodeling, the rate of bone loss, and response to treatment with estrogen in elderly women. J Clin Endocrinol Metab 2004;89:4954-62.
5. Potischman N, Hoover RN, Brinton LA, et al. Case-control study of endogenous steroid hormones and endometrial cancer. J Natl Cancer Inst 1996;88:1127-35.
6. Thijssen JH, Blankenstein MA. Endogenous oestrogens and androgens in normal and malignant endometrial and mammary tissues. Eur J Cancer Clin Oncol 1989;25:1953-9.
7. Helzlsouer KJ, Alberg AJ, Bush TL, Longcope C, Gordon GB, Comstock GW. A prospective study of endogenous hormones and breast cancer. Cancer Detect Prev 1994;18:79-85.
8. Secreto G, Toniolo P, Pisani P, et al. Androgens and breast cancer in premenopausal women. Cancer Res 1989;49:471-6.
9. Wysowski DK, Comstock GW, Helsing KJ, Lau HL. Sex hormone levels in serum in relation to the development of breast cancer. Am J Epidemiol 1987;125:791-9.
10. Thomas HV, Key TJ, Allen DS, et al. A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey. Br J Cancer 1997;75:1075-9.
11. Michaud DS, Manson JE, Spiegelman D, et al. Reproducibility of plasma and urinary sex hormone levels in premenopausal women over a one-year period. Cancer Epidemiol Biomarkers Prev 1999;8:1059-64.
12. Lenton EA, Landgren BM, Sexton L. Normal variation in the length of the luteal phase of the menstrual cycle: identification of the short luteal phase. Br J Obstet Gynaecol 1984;91:685-9.
13. Lenton EA, Landgren BM, Sexton L, Harper R. Normal variation in the length of the follicular phase of the menstrual cycle: effect of chronological age. Br J Obstet Gynaecol 1984;91:681-4.
14. Hankinson SE, London SJ, Chute CG, et al. Effect of transport conditions on the stability of biochemical markers in blood. Clin Chem 1989;35:2313-6.
15. Hankinson SE, Willett WC, Colditz GA, et al. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 1998;351:1393-6.
16. Hankinson SE, Willett WC, Manson JE, et al. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 1998;90:1292-9.
17. Hankinson SE, Willett WC, Michaud DS, et al. Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst 1999;91:629-34.
18. Abraham GE, Tulchinsky D, Korenman SG. Chromatographic purification of estradiol-17 for use in radio-ligand assay. Biochem Med 1970;3:365-8.
19. Mikhail G, Chung HW. Radioimmunoassay of plasma estrogens. Use of polymerized antibodies. In: Peron FG, Caldwells BV, editors. Immunological methods in steroid determination. New York: Appleton-Century-Croft; 1970. p. 113.
20. Mikhail G, Wu CH, Ferin M, Vande Wiele RL. Radioimmunoassay of plasma estrone and estradiol. Steroids 1970;15:333-52.
21. Kinouchi T, Pages L, Horton R. A specific radioimmunossay for testosterone in peripheral plasma. J Lab Clin Med 1973;82:309-16.
22. McNatty KP, Smith DM, Makris A, Osathanondh R, Ryan KJ. The microenvironment of the human antral follicle: interrelationships among the steroid levels in antral fluid, the population of granulosa cells, and the status of the oocyte in vivo and in vitro. J Clin Endocrinol Metab 1979;49:851-60.
23. Buster JE, Abraham GE. Radioimmunoassay of serum DHEAS. Analytic Letters 1972;543.
24. Franz C, Watson D, Longcope C. Estrone sulfate and dehydroepiandrosterone sulfate concentrations in normal subjects and men with cirrhosis. Steroids 1979;34:563-73.
25. Carey VJ, Walters EE, Colditz GA, et al. Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses' Health Study. Am J Epidemiol 1997;145:614-9.
26. Rosner B. Percentage points for generalized ESD many-outlier procedure. Technometrics 1983;25:165-72.
27. Rosner B. Fundamentals of biostatistics. Belmont (CA): Wadsworth Publishing Co; 1993.
28. Hankinson SE, Manson JE, Spiegelman D, Willett WC, Longcope C, Speizer FE. Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period. Cancer Epidemiol Biomarkers Prev 1995;4:649-54.
29. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
30. Rosner B, Spiegelman D, Willett WC. Correction of logistic regression relative risk estimates and confidence intervals for random within-person measurement error. Am J Epidemiol 1992;136:1400-13.
31. Yen SSC, Jaffe RB. Reproductive endocrinology. Philadelphia: W.B. Saunders Company; 1991.
32. Muti P, Trevisan M, Micheli A, et al. Reliability of serum hormones in premenopausal and postmenopausal women over a one-year period. Cancer Epidemiol Biomarkers Prev 1996;5:917-22.
33. Toniolo P, Koenig KL, Pasternack BS, et al. Reliability of measurements of total, protein-bound, and unbound estradiol in serum. Cancer Epidemiol Biomarkers Prev 1994;3:47-50.
34. Koenig KL, Toniolo P, Bruning PF, Bonfrer JM, Shore RE, Pasternack BS. Reliability of serum prolactin measurements in women. Cancer Epidemiol Biomarkers Prev 1993;2:411-4.
35. Micheli A, Muti P, Pisani P, et al. Repeated serum and urinary androgen measurements in premenopausal and postmenopausal women. J Clin Epidemiol 1991;44:1055-61.
36. Filicori M, Butler JP, Crowley WF, Jr. Neuroendocrine regulation of the corpus luteum in the human. Evidence for pulsatile progesterone secretion. J Clin Invest 1984;73:1638-47.
37. Muti P, Quattrin T, Grant BJ, et al. Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiol Biomarkers Prev 2002;11:1361-8.
38. Milani D, Carmichael JD, Welkowitz J, et al. Variability and reliability of single serum IGF-I measurements: impact on determining predictability of risk ratios in disease development. J Clin Endocrinol Metab 2004;89:2271-4.
39. Goodman-Gruen D, Barrett-Connor E. Epidemiology of insulin-like growth factor-I in elderly men and women. The Rancho Bernardo Study. Am J Epidemiol 1997;145:970-6.
40. Shekelle RB, Shryock AM, Paul O, et al. Diet, serum cholesterol, and death from coronary heart disease. The Western Electric study. N Engl J Med 1981;304:65-70.
41. Willett W. Nutritional epidemiology. New York: Oxford University Press, Inc.; 1998.
42. Rosner B, Hennekens CH, Kass EH, Miall WE. Age-specific correlation analysis of longitudinal blood pressure data. Am J Epidemiol 1977;106:306-13.